首页FAGR • EBR
add
Fagron NV
市场资讯
财务信息
损益表
收入
净收入
| (EUR) | 2024年12月info | 年同比变化 |
|---|---|---|
收入 | 2.21亿 | 13.08% |
经营支出 | 6790.65万 | 18.58% |
净收入 | 2006.40万 | 6.98% |
净利润率 | 9.07 | -5.32% |
每股收益 | — | — |
息税折旧摊销前利润 | 4801.55万 | 55.08% |
有效税率 | 23.27% | — |
资产负债表
总资产
负债总额
| (EUR) | 2024年12月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 1.16亿 | -15.55% |
总资产 | 10.84亿 | 7.60% |
负债总额 | 5.78亿 | 7.20% |
权益总额 | 5.05亿 | — |
发行在外的股份 | 7288.73万 | — |
市净率 | 2.68 | — |
资产回报率 | 7.73% | — |
资本回报率 | 9.40% | — |
现金流
现金净变动
| (EUR) | 2024年12月info | 年同比变化 |
|---|---|---|
净收入 | 2006.40万 | 6.98% |
来自运营的现金 | 3398.15万 | -16.46% |
投资现金 | -1307.10万 | -43.39% |
融资现金 | -1079.95万 | 48.26% |
现金净变动 | 917.60万 | -11.74% |
自由现金流 | 1616.18万 | -3.81% |
简介
Fagron NV is a publicly traded multinational group of companies governed by Belgian law. Its registered office is located in Waregem, Belgium, and its headquarters is located at Rotterdam, Netherlands. Founded as Arseus NV, it was formerly the Professional Health Division of Omega Pharma, and became an independent entity via an IPO on October 5, 2007 and has been listed on Euronext Brussels and Euronext Amsterdam since then. Its share is included in the BEL MID-index and the Amsterdam Small Cap Index. The head office of Fagron is located in Rotterdam. Wikipedia
CEO
成立时间
1990
员工数量
3,647
